NCT07054905Completed
Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG
Source: ClinicalTrials.gov · Last updated 20 Mar 2026
Brief summary (registry, in English)
This study aims to evaluate whether hyperkalemia, a potentially life-threatening condition in dialysis patients, can be detected early using a wearable single-lead ECG device. Patients with chronic kidney disease undergoing hemodialysis will wear a chest-attached ECG sensor (HiCardi) during dialysis sessions. ECG data will be collected four times over six weeks, in coordination with routine blood tests measuring serum potassium levels. The goal is to analyze changes in ECG waveforms, such as T waves, and determine if these correlate with elevated potassium levels. The study is non-interventional and observational, focusing on real-time, non-invasive monitoring. It is expected to improve clinical decision-making by enabling early detection of hyperkalemia without additional blood tests.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 32 (actual)
- First submitted
- 27 Jun 2025
- Start date
- 23 Jun 2025
- Primary completion date
- 28 Aug 2025
- Lead sponsor
- Kyungho Park
- Diseases
- Chronic kidney disease
- NCT number
- NCT07054905
What you commit to
- Study type: Observational
- Participants enrolled: 32
- From 23 Jun 2025 to the primary completion date, 28 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Significant skin conditions (e.g., severe dermatitis, burns) that prevent ECG device attachment
Other
- Refusal or inability to comply with study procedures
Who the study is looking for
- Adults aged 19 years or older
- Diagnosed with chronic kidney disease (CKD) and receiving maintenance hemodialysis three times per week
- Stable clinical condition without acute complications in the past 3 months
- Ability to understand and sign informed consent
- No physical or physiological barrier to wearing an ECG device
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chungnam National University Hospital Coordinator of this site? Confirm its status | Daejeon | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.